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Abstract
Virology Journal is an exclusively on-line, Open Access journal devoted to the presentation of high-
quality original research concerning human, animal, plant, insect bacterial, and fungal viruses.
Virology Journal will establish a strategic alternative to the traditional virology communication
process.
The outbreaks of SARS coronavirus and West Nile virus
(WNV), and the troubling increase of poliovirus infec-
tions in Africa, are but a few recent examples of the unpre-
dictable and ever-changing topography of the field of
virology. Previously unknown viruses, such as the SARS
coronavirus, may emerge at anytime, anywhere in the
world. Viruses previously thought to be geographically
restricted, such as WNV, may appear in new regions and
spread rapidly. Poliovirus, once thought to be on the
brink of elimination, has surged with a widespread distri-
bution in nearly a dozen African nations that now poses a
serious risk to the polio eradication initiative. Govern-
ments and individuals are increasingly aware of the
threats posed by viruses, including established viruses,
emerging viruses and the many viruses that are potential
agents of bioterrorism. However, lack of information or
misinformation regarding viruses can further exacerbate
their impact on public health. There is an urgent need for
a rapid forum for communications among virologists.
Virology Journal will present high-quality original
research concerning human, animal, plant, insect bacte-
rial, and fungal viruses, while establishing a strategic alter-
native to the traditional virology communication process.
Links to an extensive database of virology information on
the Internet will be provided through our "All the Virol-
ogy" (ATV) web site http://www.virology.net.
Open Access
Virology Journal's Open Access policy changes the way in
which articles in virology can be published [1]. First, all
articles are freely and universally accessible online as soon
as they are published, so an author's work can be read by
anyone at no cost. Second, the authors hold copyright for
their work and grant anyone the right to reproduce and
disseminate the article, provided that it is correctly cited
and no errors are introduced. Third, a copy of the full text
of each Open Access article is permanently archived in an
online repository separate from the journal. Virology Jour-
nal's articles are archived in PubMed Central [2], the US
National Library of Medicine's full-text repository of life
science literature, and also in repositories at the University
of Potsdam [3] in Germany, at INIST [4] in France and in
e-Depot [5], the National Library of the Netherlands' dig-
ital archive of all electronic publications.
Open Access has four broad benefits for science and the
general public. First, authors are assured that their work is
disseminated to the widest possible audience, given that
there are no barriers to access their work. This is accentu-
ated by the authors being free to reproduce and distribute
their work, for example by placing it on their institution's
website. It has been suggested that free online articles are
more highly cited because of their easier availability [6].
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Second, the information available to researchers will not
be limited by their library's budget, and the widespread
availability of articles will enhance literature searching
[7]. Third, the results of publicly funded research will be
accessible to all taxpayers and not just those with access to
a library with a subscription. As such, Open Access could
help to increase public interest in, and support of,
research. Note that this public accessibility may become a
legal requirement in the USA if the proposed Public
Access to Science Act is made law [8]. Similar calls for a
move to Open Access of all scientific research have been
made recently by the UK government [9]. Fourth, a coun-
try's economy will not influence its scientists' ability to
access articles because resource-poor countries (and insti-
tutions) will be able to read the same material as wealthier
ones (although creating access to the Internet is another
matter [10]). This is particularly relevant in virology as
many viruses have regional, rather than global, distribu-
tions.
Peer Review policy
Virology Journal will consider: research, book reports,
case reports, commentaries, debate articles, hypotheses,
methodology articles, reviews, short reports and short
protocols. An editorial board of 30 members has been
established [11]. In addition to these outstanding individ-
uals, nine other distinguished virologists constitute an
advisory board that will provide general oversight of the
journal [11]. While initially all manuscripts will be sub-
mitted to my office, as Editor-in-Chief, as the volume of
manuscripts increases, submissions in specific areas of
virology (ie. large DNA viruses, plant viruses etc) will go
directly to a Section Editor chosen by the author. The Edi-
tor-in-Chief or Section Editor will assign each research
manuscript submitted to the journal to a member of the
Editorial Board who will be known as the "monitoring
editor". The monitoring editor will then appoint at least
two ad hoc reviewers from experts in the field. Once the
reviewers have provided their feedback, the monitoring
editor makes the final recommendation. Managing Edi-
tor, David Sander will be available to assist authors with
content and formatting issues not resolved during the
review process. He will also assist the authors of review
articles with integration of content with the ATV website
(where appropriate). Articles will be published online
immediately upon acceptance and soon after listed in
PubMed.
Competing interests
Critics of Open Access often suggest that Editors have a
financial incentive to accept articles as more articles
means more revenue. However, BioMed Central insists
that decisions about a manuscript must be based on the
quality of the work, not on whether the article-processing
charge can be paid. This policy will certainly apply for
Virology Journal whose authors and readers will benefit
from learning about viruses in regions of the world with
limited financial resources. No member of the editorial or
advisory boards of Virology Journal or their Institutions
will receive any portion of the article-processing charge.
It is also a BioMed Central policy that Editors should
declare their competing interests. Several years ago, I sug-
gested that it would be a useful policy for the Editors of
scientific and medical journals to declare their competing
interests on a yearly basis [12]. Few editors have accepted
this suggestion, but by way of example I shall declare my
own here:
"I declare that my institution holds or has applied for sev-
eral United Stated and International patents based on
technology developed in my laboratory. These patents or
patent applications cover a range of technologies includ-
ing diagnostic assays, human A-type retroviruses and a B-
type retrovirus (betaretrovirus), and peptides that inhibit
viral infectivity. Tulane University has licensed some of
these technologies to private companies for commercial
development (list available on request), and I receive roy-
alties from these licenses. I have also served on several
study sections for the National Institutes of Health and
currently served as the Chair of a biodefense study section
(SSS-Z). I receive a per diem and reimbursement from the
NIH for service on the study sections. Except for mutual
funds in a retirement account managed through Tulane
University, I own no stocks or other commercial instru-
ments."
Conclusion
There are several outstanding virology journals covering
all aspects of this dynamic field, but none of the general
virology journals are exclusively published on-line or are
Open Access. With the launch of Virology Journal, we hope
to catalyse a fuller utilization of the Internet for scientific
communication in virology drawing on our long experi-
ence with the ATV website. We welcome any advice and
input.
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